Here is the group photo of the doctors who participated in the 2025 ECDGA Medical Symposium in Barcelona. erdheim-chester.org/medical-expert…

Featured today by MSK Library: Approach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder dx.doi.org/10.1210/clinem… #Endocrinology #HistiocyticDisorders #RareDiseases #DiagnosticPathways #ClinicalEndocrinology #MultisystemDisorders #MedicalEducation

Cell-of-origin as well as CNS-IPI were independently predictive of the risk for secondary #CNSlymphoma in #DLBCL, a finding that could give confidence to clinicians looking to assess the potential for this rare but serious complication #ASCO25: ow.ly/fwIL50W999O

ashpublications.org/ashclinicalnew…

ashpublications.org/ashclinicalnew…

🚨 Our new study highlights how cell of origin + CNS-IPI scores can help predict CNS relapse in #DLBCL A step forward in better risk stratification that incorporates disease-biology. Presented ASCO Read more in ASH Clinical News 👇 🔗 ashpublications.org/ashclinicalnew… #Lymphoma #CNSRelaps

Dr Ansell discussing plenary abstract ICML Lugano on predicting response to CART by microenvironment signature Mayo Clinic Comprehensive Cancer Center

Just online! Thrilled to share our work on mesenchymal dendritic cells neoplasms with focus on distinction from Histiocytic & classical dendritic/Langerhans cell neoplasms #raredisdeaseawareness Incredible work by Neha Seth and all co-authors Jithma Abeykoon, M.D. Gaurav Goyal

Our findings are important and open a new understanding of biology and novel way of therapy Mayo Clinic Comprehensive Cancer Center Witzig Laboratory JCI - Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphoma jci.org/articles/view/…

Redefining risk stratification in pLCH sciencedirect.com/science/articl… This is a significant study that redefines risk stratification in pediatric LCH. ECD Global Alliance Histiocyte Society Mayo Clinic Comprehensive Cancer Center

And now into the head and neck region. As expected, Dr. Katharine Price delivers an outstanding presentation on advances in head and neck cancer including KN-689. But who really benefits…? Mayo Clinic Med Ed Mayo Clinic Comprehensive Cancer Center Mayo Clinic Hematology-Oncology Fellowship

🔁 Re-sharing a study from our group on long-term outcomes in adult LCH 🧬 Clinical phenotypes, treatment patterns, and prognostic factors 📊 219 adults | ↑ mortality vs general population esp. among <55y and multi-system disease 🔗 tinyurl.com/yvdry9ms #LCH #RareDiseases

Very important meeting for patients with histiocytic cancers. Consider attending histiocytesociety.org/HS-2025

A comprehensive review article on the risk stratification of all plasma cell disorders by Vincent Rajkumar Saurabh Zanwar Myeloma, MGUS, SMM, Amyloid, WM — all here. Open Access. nature.com/articles/s4137…